Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...
In the United States, nearly three million adults 18 years and older reported having active epilepsy during 2021 and 2022.